-
Lipocine Announces Pricing Of Public Offering Of Common Stock And Warrants
-
Lipocine (LPCN) Announces Launch of Public Offering of Common Stock, Warrants
-
Lipocine Announces Launch Of Public Offering Of Common Stock And Warrants
-
Pre-Open Movers 11/11: (CARB) (SPWR) (WBA) Higher; (LPCN) (NXTC) (FOMX) Lower (more...)
-
Notable 52-Week Highs and Lows 7/22: (EXEL) (DVAX) (ABT) High; (XOMA) (CZR) (BEAV) Low
-
Unusual 11 Mid-Day Movers 7/22: (SLTD) (LPCN) (BZUN) Higher; (XOMA) (ANGI) (CZR) Lower
-
Pre-Open Stock Movers 07/22: (ISRG) (THOR) (EYES) Higher; (XOMA) (ILMN) (AAPL) Lower (more...)
-
Roth Capital Starts Lipocine Inc (LPCN) at Buy, $36 PT
-
Lipocine Announces Closing of $34.8 Million Common Stock Offering
-
Lipocine Prices $30.2 Million Public Offering of Common Stock
-
Lipocine Prices $30.2 Million Public Offering of Common Stock
-
Lipocine (LPCN) Prices 4.65M Common at $6.50/Sahre
-
Lipocine Prices $30.2 Million Public Offering of Common Stock
-
Lipocine Prices $30.2 Million Public Offering of Common Stock

